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The management of acute coronary syndrome (ACS) and heart failure (HF) in centenarians is specially
challenging because these patients suffer from multiple comorbidities, altered anatomy, physiology, and
response to medications compared with younger patients. Unfortunately, there are no speciﬁc guidelines
for this age group. We herein report an experience of treating a woman 101 years of age with ACS and HF,
had a complex coronary angiographic procedure, and proved to have coronary artery disease with the
involvement of multiple vessels. Due to the very high risk of being treated surgically or by transcatheter
coronary interventions, the clinical course became stable with multidisciplinary conservative medical
treatment, which resulted in survival and maintenance of quality of life.
Copyright  2011, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
Open access under CC BY-NC-ND license.LLC.1. Introduction
The number of the oldest range of elderly patients (>85 years of
age) is rising and ischemic heart disease is a major cause of death;
83% of patients dying from this disease are older than 65 years of
age.1 The management of acute coronary syndrome (ACS) and heart
failure (HF) is challenging in the elderly population because of
multiple comorbid conditions, late or atypical presentation,2
delayed medical attention, and altered cardiovascular anatomy
and physiology. The paucity of guidelines due to limited random-
ized clinical trials for nonagenarians in these clinical situations
made our treatment of a woman aged 101 years with non-ST
elevation myocardial infarction (NSTEMI) especially complex. She
had a complicated coronary angiographic procedure and proved to
have multivessel coronary disease with a very high risk for invasive
treatment. We achieved the stabilization of her clinical condition,
and she survived from this major cardiac event with our multi-
disciplinary conservative management. The literature regarding
medical management for nonagenarians in these conditions were
reviewed and herein presented.dicine, Section of Cardiology,
d, Chia-yi City 60002, Taiwan.
linical Gerontology & Geriatrics. P2. Case report
A woman aged 101 years who was able to independently
perform daily activities and who was diagnosed with type 2 dia-
betes mellitus and essential hypertension at the age of 96 was
hospitalized in the beginning of 2008 due to increasing drowsiness
since 3 days prior to admission with gradual onset of dyspnea on
the day of admission. She complained of drowsiness, and physical
examination revealed her body weight was only 35 kg, body height
was 150 cm, and body mass index (BMI) was 15.6. Her blood
pressure was 148/98 mmHg, respiratory rate was 22e24 breaths/
minute, and pulse rate was 89 beats/minute. The jugular vein was
engorged, and bilateral basal rales were impressed on chest
auscultation. A 2/6 systolic murmur was heard over the right upper
sternal area and lower extremities were edematous. Positive
laboratory data included serum creatine kinase (CPK) at 338 IU/L
(normal range: 26e140 IU/L), creatine kinase MB form (CK-MB) at
20.8 u/l (normal: 2.3e9.5 u/l), troponin-I at 13.17 ng/ml (normal:
<0.5 ng/ml), blood urea nitrogen at 42 mg/dl, serum creatinine at
1.8 mg/dl, serum hemoglobin at 7.0 g/dl, and hematocrit at 22%.
Stool occult blood test was positive. While using a nasal prong (3 L/
minute), arterial blood gas revealed pH at 7.22, PaO2 at 53.1, PCO2
at 63, HCO3 at 21.6 and base excess at e6.5. Electrocardiography
(ECG) showed normal sinus rhythm, complete right bundle branch
block, and ST depression on leads V2 to V5. Echocardiography
showed an ejection fraction (EF) of 44% estimated by M mode,ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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anterior walls of left ventricle, sclerosis on the aortic and mitral
valve leaﬂets, mild to moderate aortic valve stenosis, and mild
aortic, mitral, and tricuspid valve regurgitation.
As NSTEMI with respiratory failure was impressed, she was
intubated and supported by mechanical ventilation. Dual oral
antiplatelet therapy with clopidogrel and aspirin, intravenous
furosemide with dosage adjusted to urine output, intravenous
nitroglycerine, morphine as necessary to control chest pain, were
given. Oral enalapril was started. Atorvastatin 10 mg qd for control
of hyperlipidemia was given because her cholesterol level was
238 mg/dl and low-density lipoprotein cholesterol was 162 mg/dl.
Glycemia was controlled by regular insulin scale. Intravenous
glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa inhibitor) and anti-
thrombin therapy such as unfractionated heparin (UFH) or low
molecular weight heparin (LMWH) were not given as gastrointes-
tinal bleeding was suspected based on positive stool occult blood
and anemia. Anemia was corrected by packed red blood cell
transfusion. Intravenous lansoprazole was given, and endoscopic
evaluation was not performed due to ongoing ACS. Her
consciousness recovered a day later, but angina was still intermit-
tent. Her NSTEMI/unstable angina (UA) TIMI risk score was 6, an
early coronary angiography (CAG) was thus indicated. Approached
initially through the left radial artery using a 6 Fr sheath, the 5-Fr
catheter failed to cross the brachial artery because of severe
tortuosity and atherosclerotic stenosis of this artery (Fig. 1A). We
changed access to the right femoral artery. As the advancement of
catheters was complicated by excessive tortuosity of the abdominal
aorta and aortic arch (Fig. 1B), the engagement of catheters to
coronary arteries was difﬁcult. The CAG revealed triple vessel
disease (Fig. 2). The SYNTAX score for the multivessel and left main
coronary artery intervention was 33, which means high risk and
complexity should be treated by percutaneous coronary interven-
tions (PCI). Evaluated by the cardiovascular surgeon, the European
System for Cardiac Operative Risk Evaluation Score (EuroScore)
resulted in 16 points, equivalent to a mortality rate of 66%. Because
of the estimated high risk for both invasive therapies, conservative
treatment was decided with the patient’s and her family’s agree-
ment. Fluid and electrolytes status and hemoglobin levels were
closely monitored, and she was successfully weaned from venti-
lator after 5 days. Subsequently, we started oral bisoprolol and
isosorbide-5-mononitrates. We shifted insulin to oral antidiabetic
agents for diabetes mellitus control. She was ﬁnally discharged
after 2 weeks of hospitalization without major discomfort.Fig. 1. (A) Severe tortuosity and atherosclerotic stenosis of brachial artery;On outpatient follow-up, multidisciplinary re-evaluation
included a cardiologist, nephrologist, dietitian, pharmacist, and
physical therapist as well as the adjustment of medications in the
intervals of 2 weeks to 2 months and frequent education to her
family regarding diet and daily care. In the following 3 years, she
was able to carry on daily activities by herself with minimal help
from her daughter without major discomfort. Although she was
rehospitalized three times because of unstable angina with exac-
erbations of symptoms related to HF, these episodes were resolved
within 3e4 days with subcutaneous LMWH, ﬁne adjustment of
diuretics, beta blockers and ACEI, and anti-angina drugs. An echo-
cardiography follow-up 1 year later revealed EF was 45%. Creatinine
clearance stabilized between 24-34 ml/minutes.
Her clinical status was stable until the end of 2010, when she
was admitted again because of urosepsis. This complicated the
management of HF, requiring prolonged use of a ventilator, infusion
of dobutamine, complex adjustment of diuretics because her renal
function was deteriorating, and the estimated creatinine clearance
decreased to 11.2 ml/minute. Although glycemia control became
difﬁcult, requiring use of human isophane insulin (NPH), she was
ﬁnally discharged 6 weeks later, with very deteriorated general
condition and unable to perform daily activities by herself. She was
admitted again 1 month later because of aspiration pneumonia
with respiratory failure, further deterioration of renal function,
incontrollable heart failure, and profound septic shock in her ﬁnal
days. She did not survive from this clinical condition after a month
of hospitalization in an intensive care unit and died at the age of
104.
3. Discussion
Management of cardiovascular disease and interventional
therapy in centenarians is rarely reported. Moreover, most studies
in these ﬁelds have not included a signiﬁcant number of patients in
this age group, with the consequence that there is a paucity of
guidelines for them.
Ischemic heart disease is a leading cause of death in the elderly.1
The diagnosis and the treatment in centenarians are challenging.
This patient ﬁrst developed drowsiness and days later presented to
us with dyspnea. The drowsiness was interpreted by her daughter
as a “weakness common to all old people,” which caused delay in
medical attention. The elderly population is used to having a higher
rate of atypical presentations of ACS, as symptoms are similar or
confused with other chronic systemic diseases, and complaints are(B) excessive tortuosity of the abdominal aorta twisting the catheter.
Fig. 2. (A) Right coronary artery with chronic total occlusion; (B) critical stenosis on middle and distal segments of the left anterior descending artery, middle segment of the left
circumﬂex artery, and their branches.
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betes.2 One-half of these patients have dyspnea as a cardinal
symptom, while others may present initially with diaphoresis,
gastrointestinal symptoms, syncope, hypotension, and numbness
or pain in the left arm or both arms.3 A comparison with previous
ECG is essential because this helps to deﬁne the diagnosis of ACS.
Recognizing electrocardiographic ischemic changes in this age
group can be challenging because some studies showed that elderly
patients may have less speciﬁc ECG ﬁndings than younger patients
because of baseline arrhythmia, bundle branch blocks, old
myocardial infarction, or pacemaker pacing rhythm.2,4 Serial
follow-up of cardiac biochemical markers, such as CPK, CK MB and
a more sensitive troponin-I, can help in increasing the accuracy of
diagnosis.
This patient had low BMI (15.6), impaired renal function, anemia,
and a positive stool occult blood test. The risk of bleeding was
a major concern for use of the GP IIb/IIIa inhibitor, UFH or LMWH.
The relative cardiovascular beneﬁt of the GP IIb/IIIa inhibitors is not
consistent in the oldest group of old patients, but common to all of
GP IIb/IIIa inhibitors is the increased risk of bleeding.5 Patient
selection, adjustment to renal function, and body weight are
important to ensure the safety while using these medications.1
However, data for age subgroups of elderly patients concerning
the safety and efﬁcacy of UFH/LMWH are lacking. If used, the dosage
needs to be adjusted because of altered body composition, serum
protein levels, and changes in the renal function.1,6
Early coronary angiography was indicated due to the high
NSTEMI/UA TIMI risk score. However, performing cardiac cathe-
terization in the elderly can be challenging. This patient had
a tortuous vascular anatomy that impeded smooth engagement of
catheters to coronary arteries, and she had triple vessel disease
with very complex lesions. These anatomical alterations are not
uncommon in nonagenarians, and cardiac catheterization and PCI
in these situations can be particularly difﬁcult. The TACTICS-TIMI 18
trial7 had established the beneﬁts of PCI for the elderly as the
number needed to treat with invasive treatment to prevent one
death or myocardial infarctionwas just nine for those more than 75
years of age, at the expense of a higher risk of major bleeding, but
data for those older than 85 years old and with triple vessel disease
are unknown. Furthermore, a patient’s preference and will are
important factors to be considered.1 A case report on a very elderly
woman (96 years of age) with ST-segment elevation myocardial
infarction, and 18 months later an NSTEMI, described treatment of
both events with PCI, which proved to be feasible.8 A multicenterstudy9 also showed that both PCI and coronary artery bypass graft
(CABG) are viable options for the revascularization on the oldest
group of old patients, but the outcome is affected by left ventricular
function, renal function, the acuity of the procedure, and age itself,
because the risk increases exponentially for those older than 85
years of age. A study conducted by Bridges and colleagues10
concluded that operative mortality for cardiac surgery is highest
for nonagenarians and centenarians; therefore, careful patient
selection is needed to lower the risk of CABG. Among the risk
factors for the operative mortality, the renal function and emer-
gency/salvage surgery play important roles. In our opinion, unless
there is a speciﬁc guideline for nonagenarians, the decision-making
should be based on the SYNTAX score and the Euroscore to estimate
the risk, and treatment as present ACS and PCI guidelines suggest,
by individualizing the condition of each patient and respecting the
decision of the patient.
Diagnosing HF in centenarians needs the following consider-
ations: the reduced ability to conduct daily activities resulting
from various causes may mask cardinal symptoms and signs; the
existence of other systemic disease can confuse the clinician; the
history taking is further complicated if patient is suffering from
dementia, cognitive disorders, or sensory impairment; and
presentation with nonspeciﬁc symptoms is frequent.11 This patient
had multiple important predisposing factors of HF: coronary artery
disease, hypertension, and valvular heart disease. Later in the
clinical course, HF was precipitated by ACS, renal insufﬁciency, and
infection, which are all well-known predisposing and precipitating
factors of HF. Infections can be particularly devastating, as evi-
denced in this case with pneumonia causing death. The clinical
outcome among elderly patients is also poor if hospitalized due to
HF: 30% to 50% will be rehospitalized again within 3e6 months,
with a 5-year mortality of 70%.11e13 The goals of treatment are to
improve quality of life and functional status, relieve the symptoms,
prevent rehospitalization, and, ideally, prolong survival. However,
the challenges while treating this patient included irregular
compliance to low sodium diet due to personal habits, inability to
do exercise due to osteoarthritis, and difﬁculty instructing her on
HF-related issues due to hearing impairment. As these problems
are common among nonagenarians, the management of HF on this
patient included a cardiologist, nephrologist, dietitian, pharmacist,
and physical therapist, with close and periodical follow-up. This
kind of multidisciplinary strategy had been proven to be efﬁcient in
the management of HF,11,14 and it certainly worked on this patient.
Physiologically, the oldest population of elderly patients have
T.-K. Sun, K.-F. Lee / Journal of Clinical Gerontology & Geriatrics 2 (2011) 121e124124increased vascular resistance, decreased heart rate, and less heart
rate responsiveness despite increased circulating norepinephrine,
decreased glomerular ﬁltration rate, and a noncompensatory
ﬁltration fraction.15 All of these factors need to be considered and
the pharmacist plays an important role in the treatment.
In conclusion, the treatment of ACS and HF in centenarians is a
challenging, complex, and multidisciplinary task. Atypical presenta-
tions, physiologic differences of elderly patients, and subsequent
adjustment of drug dosage, comorbidities, and predisposing and
precipitating factors need to be considered. Goals of treatment
include improvement of life quality, relief of symptoms, and
improvement of functional status, prevention of exacerbations, and,
hopefully, prolongation of survival. Until speciﬁc guidelines are
established for nonagenarians, the present ACS/HF treatment guide-
lines should be followed, but physicians should always consider the
physiologic and anatomic differences of the oldest of elderly patients.
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